USPTO serial 79343508
PS PS128
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 14, 2024
- Examiner
- WOLD, BARBARA NIELSEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PS PS128?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
CN
CN
CN
CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yue (Robert) Xu
Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting peripheral nervous system made in whole or substantial part of Lactobacillus plantarum PS128; pharmaceutical preparations acting on the central nervous system made in whole or substantial part of Lactobacillus plantarum PS128; medicated candies made in whole or substantial part of Lactobacillus plantarum PS128; dietetic foods adapted for medical use made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for veterinary purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; Preparations of microorganisms for medical or veterinary use made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, stress, separation anxiety, aggression, compulsive disorder, excessive barking, yowl and stabilize emotional status; nutraceutical preparations for therapeutic or medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; milk ferments for pharmaceutical purposes made in whole or substantial part of Lactobacillus plantarum PS128; biological preparations for medical purposes made in whole or substantial part of Lactobacillus plantarum PS128 for the treatment of autism spectrum disorder, Parkinson's disease, Alzheimer's disease, depressive disorder, Tourette syndrome, visceral hypersensitivity, constipation, insomnia, and stress; powdered whey proteins being nutritional supplements made in whole or substantial part of Lactobacillus plantarum PS128 | ACTIVE | — |
| 029 | Yogurt made in whole or substantial part of Lactobacillus plantarum PS128; whey made in whole or substantial part of Lactobacillus plantarum PS128; milk products made in whole or substantial part of Lactobacillus plantarum PS128 namely, milk-based nutritional supplement drinks; milk ferments for culinary purposes made in whole or substantial part of Lactobacillus plantarum PS128; powdered milk made in whole or substantial part of Lactobacillus plantarum PS128; beverages having a milk base made in whole or substantial part of Lactobacillus plantarum PS128; yogurt drinks made in whole or substantial part of Lactobacillus plantarum PS128; milk solids made in whole or substantial part of Lactobacillus plantarum PS128 | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bened Biomedical Co., Ltd.
- Other trademarks owned by Bened Biomedical Co.,Ltd.
- Other trademarks owned by Bened Biomedical Co.,Ltd.
- Other trademarks owned by Bened Biomedical Co.,Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 029
- Similar marks named PS PS128
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 7, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 7, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 14, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 14, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 14, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 23, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 25, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 21, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 21, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 4, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 3, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 5, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 30, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |